Aberrant expression of NF-κB in liver fluke associated cholangiocarcinoma: Implications for targeted therapy

PLoS ONE

Volumn 9, Issue 8, 2014, Pages

  Seubwai, Wunchana ^a   Wongkham, Chaisiri ^a   Puapairoj, Anucha ^a   Khuntikeo, Narong ^a   Pugkhem, Ake ^a   Hahnvajanawong, Chariya ^a   Chaiyagool, Jariya ^a   Umezawa, Kazuo ^b   Okada, Seiji ^c   Wongkham, Sopit ^a  

^a KHON KAEN UNIVERSITY   (Thailand)

^b AICHI MEDICAL UNIVERSITY   (Japan)

^c KUMAMOTO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTEIN BCL 2; TRANSCRIPTION FACTOR RELA; X LINKED INHIBITOR OF APOPTOSIS; BENZAMIDE DERIVATIVE; CYCLOHEXANONE DERIVATIVE; DEHYDROXYMETHYLEPOXYQUINOMICIN; JAK3 PROTEIN, MOUSE; JANUS KINASE 3;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BILE DUCT CARCINOMA; CARCINOGENESIS; CELL CYCLE G2 PHASE; CELL GROWTH; CLINICAL ARTICLE; CONTROLLED STUDY; DNA FRAGMENTATION; ENZYME ACTIVATION; FASCIOLA HEPATICA; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; MALE; MOLECULAR PATHOLOGY; MOUSE; NICK END LABELING; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN TARGETING; TUMOR VOLUME; ANIMAL; ANTAGONISTS AND INHIBITORS; BILE DUCT TUMOR; BIOSYNTHESIS; COMPLICATION; DEFICIENCY; DOSE RESPONSE; DRUG EFFECTS; DRUG SCREENING; GENETICS; HOST PARASITE INTERACTION; INTRAHEPATIC BILE DUCT; KNOCKOUT MOUSE; LIVER; METABOLISM; MIDDLE AGED; NONOBESE DIABETIC MOUSE; OPISTHORCHIASIS; OPISTHORCHIS; PARASITOLOGY; PATHOLOGY; PHYSIOLOGY; SCID MOUSE; WESTERN BLOTTING;

ANIMALS; APOPTOSIS; BENZAMIDES; BILE DUCT NEOPLASMS; BILE DUCTS, INTRAHEPATIC; BLOTTING, WESTERN; CHOLANGIOCARCINOMA; CYCLOHEXANONES; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HOST-PARASITE INTERACTIONS; HUMANS; IMMUNOHISTOCHEMISTRY; JANUS KINASE 3; LIVER; MALE; MICE, INBRED NOD; MICE, KNOCKOUT; MICE, SCID; MIDDLE AGED; NF-KAPPA B; OPISTHORCHIASIS; OPISTHORCHIS; TUMOR BURDEN; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84925476516     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0106056     Document Type: Article

References (47)

1. Sripa B, Pairojkul C (2008) Cholangiocarcinoma: lessons from Thailand. Curr Opin Gastroenterol 24: 349-356. (Pubitemid 351535894)
2. Sripa B, Brindley PJ, Mulvenna J, Laha T, Smout MJ, et al. (2012) The tumorigenic liver fluke Opisthorchis viverrini-multiple pathways to cancer. Trends Parasitol 28: 395-407.
3. Shin HR, Oh JK, Masuyer E, Curado MP, Bouvard V, et al. (2010) Epidemiology of cholangiocarcinoma: an update focusing on risk factors. Cancer Sci 101: 579-585.
4. Srivatanakul P, Ohshima H, Khlat M, Parkin M, Sukaryodhin S, et al. (1991) Opisthorchis viverrini infestation and endogenous nitrosamines as risk factors for cholangiocarcinoma in Thailand. Int J Cancer 48: 821-825.
5. The Bureau of Policy and Strategy MoPh, Thailand (2010) Public health Statistic 2010.
6. Kamsa-ard S, Wiangnon S, Suwanrungruang K, Promthet S, Khuntikeo N, et al. (2011) Trends in liver cancer incidence between 1985 and 2009, Khon Kaen, Thailand: cholangiocarcinoma. Asian Pac J Cancer Prev 12: 2209-2213.
7. Brown M, Cohen J, Arun P, Chen Z, Van Waes C (2008) NF-kappaB in carcinoma therapy and prevention. Expert Opin Ther Targets 12: 1109-1122.
8. Mauro C, Zazzeroni F, Papa S, Bubici C, Franzoso G (2009) The NF-kappaB transcription factor pathway as a therapeutic target in cancer: methods for detection of NF-kappaB activity. Methods Mol Biol 512: 169-207.
9. Shen HM, Tergaonkar V (2009) NFkappaB signaling in carcinogenesis and as a potential molecular target for cancer therapy. Apoptosis 14: 348-363.
10. Van Waes C (2007) Nuclear factor-kappaB in development, prevention, and therapy of cancer. Clin Cancer Res 13: 1076-1082.
11. Fahy BN, Schlieman MG, Virudachalam S, Bold RJ (2004) Inhibition of AKT abrogates chemotherapy-induced NF-kappaB survival mechanisms: implications for therapy in pancreatic cancer. J Am Coll Surg 198: 591-599. (Pubitemid 38446534)
12. Yeh PY, Chuang SE, Yeh KH, Song YC, Cheng AL (2003) Involvement of nuclear transcription factor-kappa B in low-dose doxorubicin-induced drug resistance of cervical carcinoma cells. Biochem Pharmacol 66: 25-33. (Pubitemid 36724896)
13. Cheng JC, Chou CH, Kuo ML, Hsieh CY (2006) Radiation-enhanced hepatocellular carcinoma cell invasion with MMP-9 expression through PI3K/Akt/NF-kappaB signal transduction pathway. Oncogene 25: 7009-7018. (Pubitemid 44722069)
14. Madhusoodhanan R, Natarajan M, Veeraraghavan J, Herman TS, Aravindan N (2009) NFkappaB activity and transcriptional responses in human breast adenocarcinoma cells after single and fractionated irradiation. Cancer Biol Ther 8: 765-773.
15. Ban JO, Oh JH, Hwang BY, Moon DC, Jeong HS, et al. (2009) Inflexinol inhibits colon cancer cell growth through inhibition of nuclear factor-kappaB activity via direct interaction with p50. Mol Cancer Ther 8: 1613-1624.
16. Liu M, Ju X, Willmarth NE, Casimiro MC, Ojeifo J, et al. (2009) Nuclear factor-kappaB enhances ErbB2-induced mammary tumorigenesis and neoangiogenesis in vivo. Am J Pathol 174: 1910-1920.
17. Furuta H, Osawa K, Shin M, Ishikawa A, Matsuo K, et al. (2012) Selective inhibition of NF-kappaB suppresses bone invasion by oral squamous cell carcinoma in vivo. Int J Cancer 131: E625-635.
18. Stein SJ, Baldwin AS (2011) NF-kappaB suppresses ROS levels in BCR-ABL(+) cells to prevent activation of JNK and cell death. Oncogene 30: 4557-4566.
19. Godwin P, Baird AM, Heavey S, Barr MP, O'Byrne KJ, et al. (2013) Targeting nuclear factor-kappa B to overcome resistance to chemotherapy. Front Oncol 3: 120.
20. Solomon LA, Ali S, Banerjee S, Munkarah AR, Morris RT, et al. (2008) Sensitization of ovarian cancer cells to cisplatin by genistein: the role of NF-kappaB. J Ovarian Res 1: 9.
21. Seubwai W, Vaeteewoottacharn K, Hiyoshi M, Suzu S, Puapairoj A, et al. (2010) Cepharanthine exerts antitumor activity on cholangiocarcinoma by inhibiting NF-kappaB. Cancer Sci 101: 1590-1595.
22. Sripa B, Leungwattanawanit S, Nitta T, Wongkham C, Bhudhisawasdi V, et al. (2005) Establishment and characterization of an opisthorchiasis-associated cholangiocarcinoma cell line (KKU-100). World J Gastroenterol 11: 3392-3397. (Pubitemid 40873244)
23. Kodera Y, Ito S, Fujiwara M, Mochizuki Y, Ohashi N, et al. (2006) In vitro chemosensitivity test to predict chemosensitivity for paclitaxel, using human gastric carcinoma tissues. Int J Clin Oncol 11: 449-453. (Pubitemid 44974398)
24. Fujita Y, Hiramatsu M, Kawai M, Nishimura H, Miyamoto A, et al. (2009) Histoculture drug response assay predicts the postoperative prognosis of patients with esophageal cancer. Oncol Rep 21: 499-505.
25. Pinlaor S, Hiraku Y, Yongvanit P, Tada-Oikawa S, Ma N, et al. (2006) iNOS-dependent DNA damage via NF-kappaB expression in hamsters infected with Opisthorchis viverrini and its suppression by the antihelminthic drug praziquantel. Int J Cancer 119: 1067-1072. (Pubitemid 44116914)
26. Ariga A, Namekawa J, Matsumoto N, Inoue J, Umezawa K (2002) Inhibition of tumor necrosis factor-alpha -induced nuclear translocation and activation of NF-kappa B by dehydroxymethylepoxyquinomicin. J Biol Chem 277: 24625-24630. (Pubitemid 34951991)
27. Yamamoto M, Horie R, Takeiri M, Kozawa I, Umezawa K (2008) Inactivation of NF-kappaB components by covalent binding of (-)- dehydroxymethylepoxyquinomicin to specific cysteine residues. J Med Chem 51: 5780-5788.
28. Hayashi S, Sakurai H, Hayashi A, Tanaka Y, Hatashita M, et al. (2010) Inhibition of NF-kappaB by combination therapy with parthenolide and hyperthermia and kinetics of apoptosis induction and cell cycle arrest in human lung adenocarcinoma cells. Int J Mol Med 25: 81-87.
29. Du HP, Shen JK, Yang M, Wang YQ, Yuan XQ, et al. (2010) 4-Chlorobenzoyl berbamine induces apoptosis and G2/M cell cycle arrest through the PI3K/Akt and NF-kappaB signal pathway in lymphoma cells. Oncol Rep 23: 709-716.
30. Zhang L, Ruan J, Yan L, Li W, Wu Y, et al. (2012) Xanthatin induces cell cycle arrest at G2/M checkpoint and apoptosis via disrupting NF-kappaB pathway in A549 non-small-cell lung cancer cells. Molecules 17: 3736-3750.
31. Uen YH, Liu DZ, Weng MS, Ho YS, Lin SY (2007) NF-kappaB pathway is involved in griseofulvin-induced G2/M arrest and apoptosis in HL-60 cells. J Cell Biochem 101: 1165-1175.
32. Meng Z, Lou S, Tan J, Xu K, Jia Q, et al. (2012) Nuclear factor-kappa B inhibition can enhance apoptosis of differentiated thyroid cancer cells induced by 131I. PLoS One 7: e33597.
33. Hussain AR, Ahmed M, Al-Jomah NA, Khan AS, Manogaran P, et al. (2008) Curcumin suppresses constitutive activation of nuclear factor-kappa B and requires functional Bax to induce apoptosis in Burkitt's lymphoma cell lines. Mol Cancer Ther 7: 3318-3329.
34. Rahman KW, Sarkar FH (2005) Inhibition of nuclear translocation of nuclear factor-{kappa}B contributes to 3,3′-diindolylmethane-induced apoptosis in breast cancer cells. Cancer Res 65: 364-371.
35. Starenki DV, Namba H, Saenko VA, Ohtsuru A, Maeda S, et al. (2004) Induction of thyroid cancer cell apoptosis by a novel nuclear factor kappaB inhibitor, dehydroxymethylepoxyquinomicin. Clin Cancer Res 10: 6821-6829. (Pubitemid 39383030)
36. Matsumoto G, Namekawa J, Muta M, Nakamura T, Bando H, et al. (2005) Targeting of nuclear factor kappaB Pathways by dehydroxymethylepoxyquinomicin, a novel inhibitor of breast carcinomas: antitumor and antiangiogenic potential in vivo. Clin Cancer Res 11: 1287-1293. (Pubitemid 40175782)
37. Kodaira K, Kikuchi E, Kosugi M, Horiguchi Y, Matsumoto K, et al. (2010) Potent cytotoxic effect of a novel nuclear factor-kappaB inhibitor dehydroxymethylepoxyquinomicin on human bladder cancer cells producing various cytokines. Urology 75: 805-812.
38. Yasuda A, Kondo S, Nagumo T, Tsukamoto H, Mukudai Y, et al. (2011) Antitumor activity of dehydroxymethylepoxyquinomicin against human oral squamous cell carcinoma cell lines in vitro and in vivo. Oral Oncol 47: 334-339.
39. Nishimura D, Ishikawa H, Matsumoto K, Shibata H, Motoyoshi Y, et al. (2006) DHMEQ, a novel NF-kappaB inhibitor, induces apoptosis and cell-cycle arrest in human hepatoma cells. Int J Oncol 29: 713-719.
40. Umezawa K (2006) Inhibition of tumor growth by NF-kappaB inhibitors. Cancer Sci 97: 990-995.
41. Umezawa K, Chaicharoenpong C (2002) Molecular design and biological activities of NF-kappaB inhibitors. Mol Cells 14: 163-167. (Pubitemid 41594968)
42. Fukushima T, Kawaguchi M, Yorita K, Tanaka H, Takeshima H, et al. (2012) Antitumor effect of dehydroxymethylepoxyquinomicin, a small molecule inhibitor of nuclear factor-kappaB, on glioblastoma. Neuro Oncol 14: 19-28.
43. Onori P, DeMorrow S, Gaudio E, Franchitto A, Mancinelli R, et al. (2009) Caffeic acid phenethyl ester decreases cholangiocarcinoma growth by inhibition of NF-kappaB and induction of apoptosis. Int J Cancer 125: 565-576.
44. Prakobwong S, Gupta SC, Kim JH, Sung B, Pinlaor P, et al. (2011) Curcumin suppresses proliferation and induces apoptosis in human biliary cancer cells through modulation of multiple cell signaling pathways. Carcinogenesis 32: 1372-1380.
45. Uthaisar K, Seubwai W, Srikoon P, Vaeteewoottacharn K, Sawanyawisuth K, et al. (2012) Cepharanthine suppresses metastatic potential of human cholangiocarcinoma cell lines. Asian Pac J Cancer Prev 13 Suppl: 149-154.
46. Kozakai N, Kikuchi E, Hasegawa M, Suzuki E, Ide H, et al. (2012) Enhancement of radiosensitivity by a unique novel NF-kappaB inhibitor, DHMEQ, in prostate cancer. Br J Cancer 107: 652-657.
47. Suzuki K, Aiura K, Matsuda S, Itano O, Takeuchi O, et al. (2013) Combined effect of dehydroxymethylepoxyquinomicin and gemcitabine in a mouse model of liver metastasis of pancreatic cancer. Clin Exp Metastasis 30: 381-392.